Research classified by Journal of Economic Literature (JEL) codes

2022

• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022, "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers, NIPE - Universidade do Minho, number 3/2022.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022, "The price of cost-effectiveness thresholds," NIPE Working Papers, NIPE - Universidade do Minho, number 5/2022.
• Ana-Cristina Balgar, 2022, "The Strategic Role of Sino-U.S. Bilateral Investments in China’s Advance in the Field of Biotechnologies," Global Economic Observer, "Nicolae Titulescu" University of Bucharest, Faculty of Economic Sciences;Institute for World Economy of the Romanian Academy, volume 10, issue 1, pages 49-62, June.
• Andrew Brown & Frithjof Laubinger & Peter Börkey, 2022, "Monitoring trade in plastic waste and scrap 2022," OECD Environment Working Papers, OECD Publishing, number 194, Apr, DOI: 10.1787/8f3e9c56-en.
• Guillermo Hernández & Miguel Amaral, 2022, "Case studies on agile regulatory governance to harness innovation: Civilian drones and bio-solutions," OECD Regulatory Policy Working Papers, OECD Publishing, number 18, Aug, DOI: 10.1787/0fa5e0e6-en.
• Adam Jørring & Andrew W Lo & Tomas J Philipson & Manita Singh & Richard T Thakor, 2022, "Sharing R&D Risk in Healthcare via FDA Hedges
  [Bank lines of credit as contingent liquidity: Covenant violations and their implications]," The Review of Corporate Finance Studies, Society for Financial Studies, volume 11, issue 4, pages 880-922.
• Alberto Cavaliere & Ashin Moayedizadeh, 2022, "Competition between Generic and Brand Name Drugs: New Evidence from the U.S. Pharmaceutical Market," DEM Working Papers Series, University of Pavia, Department of Economics and Management, number 209, Dec.
• Hu, Mei-Ying & Lu, You-Xun & Lai, Ching-Chong, 2022, "Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis," MPRA Paper, University Library of Munich, Germany, number 113923, Jul.
• Yumi Park, 2022, "Policies and Corporate Responses to the Plastic Pollution Crisis," Industrial Economic Review, Korea Institute for Industrial Economics and Trade, number 22-10, Jun.
• Frank R. Lichtenberg, 2022, "The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017," Journal of Evolutionary Economics, Springer, volume 32, issue 4, pages 1155-1173, September, DOI: 10.1007/s00191-022-00777-4.
• Justus Haucap & Leon Knoke, 2022, "Warum und wie die Liberalisierung des Cannabismarktes in Deutschland erfolgen sollte
  [Why and How the Liberalisation of the Cannabis Market in Germany Should Occur]," Wirtschaftsdienst, Springer;ZBW - Leibniz Information Centre for Economics, volume 102, issue 1, pages 32-39, January, DOI: 10.1007/s10273-022-3091-x.
• Fabian Gaessler & Stefan Wagner, 2022, "Patents, Data Exclusivity, and the Development of New Drugs," The Review of Economics and Statistics, MIT Press, volume 104, issue 3, pages 571-586, May, DOI: 10.1162/rest_a_00987.
• Bortnowska Hanna & Seiler Bartosz, 2022, "CSR in mission statements of Polish chemical industry companies (content analysis results)," Management, Sciendo, volume 26, issue 2, pages 1-23, December, DOI: 10.2478/manment-2019-0093.
• Adatto, Laurent & Aouinaït, Camille & Le, Son Thi Kim & Mongo, Michelle, 2022, "Industrial and Organizational Mutations in the Medical and Pharmaceutical Sectors impulsed by Open Innovation during the Pandemic," Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference (2022), Hybrid Conference, Opatija, Croatia, IRENET - Society for Advancing Innovation and Research in Economy, Zagreb, "Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference, Hybrid Conference, Opatija, Croatia, 17-18 June 2022", DOI: 10.54820/entrenova-2022-0035.
• Kirchhoff, Jasmina, 2022, "Arzneimittelversorgung und -produktion gefährdet: AMNOG-Reform auf dem Prüfstand," IW policy papers, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 8/2022.
• Kirchhoff, Jasmina, 2022, "Vorleistungsverflechtungen der deutschen Pharmaindustrie im internationalen Vergleich," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 49, issue 1, pages 3-19, DOI: 10.2373/1864-810X.22-01-01.
• Grömling, Michael, 2022, "Produktivitätseffekte der Kapitalbildung in Deutschland," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 49, issue 2, pages 3-25, DOI: 10.2373/1864-810X.22-02-01.
• Kirchhoff, Jasmina & Malin, Lydia & Schumacher, Simon, 2022, "Pharmaindustrie im Wandel: Fachkräftebedarfe in Zeiten transformatorischer Herausforderungen
  [Pharmaceuticals in transition: The need for skilled labour in an era of digital transformation]," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 49, issue 2, pages 97-116, DOI: 10.2373/1864-810X.22-02-05.

2021

• Florian Heiss & Daniel McFadden & Joachim Winter & Amelie Wuppermann & Bo Zhou, 2021, "Inattention and Switching Costs as Sources of Inertia in Medicare Part D," American Economic Review, American Economic Association, volume 111, issue 9, pages 2737-2781, September, DOI: 10.1257/aer.20170471.
• David Dranove & Christopher Ody & Amanda Starc, 2021, "A Dose of Managed Care: Controlling Drug Spending in Medicaid," American Economic Journal: Applied Economics, American Economic Association, volume 13, issue 1, pages 170-197, January, DOI: 10.1257/app.20190165.
• Wallace P. Mullin & Christopher M. Snyder, 2021, "A Simple Method for Bounding the Elasticity of Growing Demand with Applications to the Analysis of Historic Antitrust Cases," American Economic Journal: Microeconomics, American Economic Association, volume 13, issue 4, pages 172-217, November, DOI: 10.1257/mic.20190012.
• Amanda Starc & Ashley Swanson, 2021, "Preferred Pharmacy Networks and Drug Costs," American Economic Journal: Economic Policy, American Economic Association, volume 13, issue 3, pages 406-446, August, DOI: 10.1257/pol.20180489.
• Lauren Cohen & Umit G. Gurun & Danielle Li, 2021, "Internal Deadlines, Drug Approvals, and Safety Problems," American Economic Review: Insights, American Economic Association, volume 3, issue 1, pages 67-82, March, DOI: 10.1257/aeri.20200086.
• Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Canice Prendergast & Christopher M. Snyder & Ale, 2021, "Preparing for a Pandemic: Accelerating Vaccine Availability," AEA Papers and Proceedings, American Economic Association, volume 111, pages 331-335, May, DOI: 10.1257/pandp.20211103.
• Efraim Benmelech & Janice Eberly & Dimitris Papanikolaou & Joshua Krieger, 2021, "Private and Social Returns to R&D: Drug Development and Demographics," AEA Papers and Proceedings, American Economic Association, volume 111, pages 336-340, May, DOI: 10.1257/pandp.20211104.
• Maya Durvasula & Lisa Larrimore Ouellette & Heidi Williams, 2021, "Private and Public Investments in Biomedical Research," AEA Papers and Proceedings, American Economic Association, volume 111, pages 341-345, May, DOI: 10.1257/pandp.20211105.
• David M. Cutler & Edward L. Glaeser, 2021, "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," Journal of Economic Perspectives, American Economic Association, volume 35, issue 4, pages 171-196, Fall, DOI: 10.1257/jep.35.4.171.
• Mariia Shkolnykova, 2021, "On the way from invention to innovation: the role of applicant and inventor team characteristics," Bremen Papers on Economics & Innovation, University of Bremen, Faculty of Business Studies and Economics, number 2110, Dec, DOI: https://doi.org/10.26092/elib/1284.
• Alla Dunska & Kateryna Boiarynova & Maryna Kravchenko, 2021, "Scientific Approach To Determining The Vectors Of Innovative Development Of Industrial Enterprises," Baltic Journal of Economic Studies, Publishing house "Baltija Publishing", volume 7, issue 4, DOI: 10.30525/2256-0742/2021-7-4-231-242.
• Amrita Ahuja & Susan Athey & Arthur Baker & Eric Budish & Juan Camilo Castillo & Rachel Glennerster & Scott Duke Kominers & Michael Kremer & Jean Lee & Candice Prendergast & Christopher M. Snyder & Al, 2021, "Preparing for a Pandemic: Accelerating Vaccine Availability," Working Papers, Becker Friedman Institute for Research In Economics, number 2021-08.
• Gérard de Pouvourville, 2021, "Logique médicale, économique, industrielle et politique dans la définition du « prix » du médicament," Revue d'économie financière, Association d'économie financière, volume 0, issue 3, pages 213-229.
• Congressional Budget Office, 2021, "Research and Development in the Pharmaceutical Industry," Reports, Congressional Budget Office, number 57025, Apr.
• Katrin Demmelhuber, 2021, "Branchen im Fokus: Einzelhandel – Apotheken," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, volume 74, issue 03, pages 63-69, March.
• Nicol√°s de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021, "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," Documentos CEDE, Universidad de los Andes, Facultad de Economía, CEDE, number 18705, Jan.
• Filiberto Enrique Valdés Medina & Mar�a Luisa Saavedra Garc�a & Antonio Alejandro Guti�rrez Navarro, 2021, "Análisis del impacto de la pandemia COVID-19 en las cotizaciones de las empresas farmacéuticas listadas en el índice NYSE," Revista Cuadernos de Economia, Universidad Nacional de Colombia, FCE, CID, volume 40, issue 85, pages 1033-1053.
• Verhoogen, Eric & de Roux, Nicolás & Eslava, Marcela & Franco, Santiago, 2021, "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 15626, Jan.
• Anderson, Simon & Renault, Régis, 2021, "Search Direction: Position Externalities and Position Auction Bias," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 16724, Nov.
• Xi Sun & Frederik Lettow & Karsten Neuhoff, 2021, "Climate Neutrality Requires Coordinated Measures for High Quality Recycling," DIW Weekly Report, DIW Berlin, German Institute for Economic Research, volume 11, issue 26, pages 187-195.
• Xi Sun & Frederik Lettow & Karsten Neuhoff, 2021, "Klimaneutralität braucht koordinierte Maßnahmen zur Stärkung von hochwertigem Recycling," DIW Wochenbericht, DIW Berlin, German Institute for Economic Research, volume 88, issue 26, pages 443-452.
• Conti, Annamaria & Ortega, Leonardo & Sung, Elie, 2021, "Sharpen your Sword for Litigation: Incumbent Strategic Reaction to the Threat of Entry," HEC Research Papers Series, HEC Paris, number 1448, Dec, DOI: 10.2139/ssrn.3949676.
• Ahuja, Amrita & Athey, Susan & Baker, Arthur & Budish, Eric & Camilo Castillo, Juan & Glennerster, Rachel & Kominers, Scott Duke & Kremer, Michael & Lee, Jean & Prendergast, Canice & Snyder, Christoph, 2021, "Preparing for a Pandemic: Accelerating Vaccine Availability," Research Papers, Stanford University, Graduate School of Business, number 3966, Jan.
• Komang Adi Kurniawan Saputra & Daniel T. H. Manurung & Lia Rachmawati & Eka Siskawati & Franklin Kharisma Genta, 2021, "Combining the Concept of Green Accounting with the Regulation of Prohibition of Disposable Plastic Use," International Journal of Energy Economics and Policy, Econjournals, volume 11, issue 4, pages 84-90.
• Zhang, Xuan & Nie, Huihua, 2021, "Public health insurance and pharmaceutical innovation: Evidence from China," Journal of Development Economics, Elsevier, volume 148, issue C, DOI: 10.1016/j.jdeveco.2020.102578.
• Befort, N., 2021, "The promises of drop-in vs. functional innovations: The case of bioplastics," Ecological Economics, Elsevier, volume 181, issue C, DOI: 10.1016/j.ecolecon.2020.106886.
• Higgins, Matthew J. & Yan, Xin & Chatterjee, Chirantan, 2021, "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," Research Policy, Elsevier, volume 50, issue 1, DOI: 10.1016/j.respol.2020.104126.
• Kristie Briggs, 2021, "Prescribing originality: investigating the impact of original knowledge on patent quality in the pharmaceutical sector," Journal of Entrepreneurship and Public Policy, Emerald Group Publishing Limited, volume 10, issue 1, pages 78-97, February, DOI: 10.1108/JEPP-09-2020-0071.
• Urszula Mikiewicz & Miroslaw Moroz, 2021, "Trade-Offs Occurring in the Process of Commercialization of SARS-CoV-2 Test in a Narrow Window of Opportunity," European Research Studies Journal, European Research Studies Journal, volume 0, issue 2 - Part , pages 294-313.
• Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021, "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Sciences Po Economics Publications (main), HAL, number hal-04114900, Oct.
• Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021, "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Working Papers, HAL, number hal-04114900, Oct.
• Gérard Mondello, 2021, "Building Belief Systems And Medical Ethics: The Covid-19 Controversies," Working Papers, HAL, number halshs-03502609, Dec.
• Gérard Mondello, 2021, "Construction De Systèmes De Croyances Et Éthique Médicale: Les Controverses Autour Du Covid-19," Working Papers, HAL, number halshs-03502610, Dec.
• Ana-Cristina Bâlgăr, 2021, "Sino-Us Bilateral Investment: Active Tools For China'S Advance In Biotechnology," Revista de Economie Mondiala / The Journal of Global Economics, Institute for World Economy, Romanian Academy, volume 13, issue 2, pages 48-65.
• Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021, "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, volume 57, issue 1, pages 603-634, June, DOI: 10.1007/s11187-019-00307-w.
• Ruoya Wang & Yaodong Zhou, 2021, "Can R&D Input Influence Market Power? Facts about China's Pharmaceutical Manufacturing Industry," Journal of Institutional and Theoretical Economics (JITE), Mohr Siebeck, Tübingen, volume 177, issue 4, pages 428-448, DOI: 10.1628/jite-2021-0015.
• Emanuela Sirtori & Alessandra Caputo & Domenico Scalera, 2021, "Patterns of development in the European biopharmaceutical industry. A network analysis of cross-sectoral linkages (2000-2016)," Working Papers, CSIL Centre for Industrial Studies, number 202101, Jul.
• Nicolás de Roux & Marcela Eslava & Santiago Franco & Eric Verhoogen, 2021, "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," NBER Working Papers, National Bureau of Economic Research, Inc, number 28323, Jan.
• Efraim Benmelech & Janice C. Eberly & Joshua L. Krieger & Dimitris Papanikolaou, 2021, "Private and Social Returns to R&D: Drug Development and Demographics," NBER Working Papers, National Bureau of Economic Research, Inc, number 28355, Jan.
• Thomas Jungbauer & Sean Nicholson & June Pan & Michael Waldman & Lucy Xiaolu Wang, 2021, "The Organization of Innovation: Incomplete Contracts and the Outsourcing Decision," NBER Working Papers, National Bureau of Economic Research, Inc, number 28379, Jan.
• Mayank Aggarwal & Anindya Chakrabarti & Chirantan Chatterjee & Matthew J. Higgins, 2021, "Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak," NBER Working Papers, National Bureau of Economic Research, Inc, number 28840, May.
• Dennis Byrski & Fabian Gaessler & Matthew J. Higgins, 2021, "Market Size and Research: Evidence from the Pharmaceutical Industry," NBER Working Papers, National Bureau of Economic Research, Inc, number 28858, May.
• Xuelin Li & Andrew W. Lo & Richard T. Thakor, 2021, "Paying off the Competition: Contracting, Market Power, and Innovation Incentives," NBER Working Papers, National Bureau of Economic Research, Inc, number 28964, Jun.
• Sharat Ganapati & Rebecca McKibbin, 2021, "Markups and Fixed Costs in Generic and Off-Patent Pharmaceutical Markets," NBER Working Papers, National Bureau of Economic Research, Inc, number 29206, Sep.
• Casey B. Mulligan, 2021, "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers, National Bureau of Economic Research, Inc, number 29574, Dec.
• Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2021, "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," NIPE Working Papers, NIPE - Universidade do Minho, number 01/2021.
• Doina Margaritti & Cristina Tase & Sirma Tomos, 2021, "Management of the Pharmaceutical Entity's Resources in the Conditions of the Sanitary Crisis of COVID-19," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, volume 0, issue 2, pages 816-822, December.
• Billette de Villemeur, Etienne & Scannell, Jack & Versaevel, Bruno, 2021, "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," MPRA Paper, University Library of Munich, Germany, number 108233.
• Robert Clark & Christopher Anthony Fabiilli & Laura Lasio, 2021, "Collusion in the US Generic Drug Industry," Working Paper, Economics Department, Queen's University, number 1474, Nov.
• Jung Min Han, 2021, "The Recent Upturn in Korea’s Exports: Background and Implications," i-KIET Issues and Analysis, Korea Institute for Industrial Economics and Trade, number 21/12, Jun.
• Woojung Shim & Heekwon Kyung, 2021, "Analysis of the 3D Printing Industry's Competitiveness across the Value Chain and Policy Implications," Research Papers, Korea Institute for Industrial Economics and Trade, number 21/5, Jul.
• Marie Coris & Alain Piveteau & Philippe Gorry & Matthieu Montalban, 2021, "Sécurité sanitaire sous dépendance. Une construction politique à repenser
  [Beyond health security dependencies. Rethinking public health and industrial policies construction]," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, volume 29, DOI: 10.4000/regulation.20065.
• Tristan Becker & Bastian Bruns & Stefan Lier & Brigitte Werners, 2021, "Decentralized modular production to increase supply chain efficiency in chemical markets," Journal of Business Economics, Springer, volume 91, issue 6, pages 867-895, August, DOI: 10.1007/s11573-020-01019-4.
• Ute Laermann-Nguyen & Martin Backfisch, 2021, "Innovation crisis in the pharmaceutical industry? A survey," SN Business & Economics, Springer, volume 1, issue 12, pages 1-37, December, DOI: 10.1007/s43546-021-00163-5.
• Giovanni Dosi & Luigi Marengo & Jacopo Staccioli & Maria Enrica Virgillito, 2021, "Big pharma and monopoly capitalism: A long-term view," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2021/26, Aug.
• Giovanni Dosi & Elisa Palagi & Andrea Roventini & Emanuele Russo, 2021, "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," LEM Papers Series, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy, number 2021/37, Oct.
• Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2021, "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," Climate Policy, Taylor & Francis Journals, volume 21, issue 10, pages 1328-1346, November, DOI: 10.1080/14693062.2021.1922340.
• Mariya V. Podshivalova & Sattar K.Kh. Almrshed, 2021, "Managing the innovation potential of small high-tech enterprises," Upravlenets, Ural State University of Economics, volume 12, issue 4, pages 16-27, September, DOI: 10.29141/2218-5003-2021-12-4-2.
• Chiappinelli, Olga & Gerres, Timo & Neuhoff, Karsten & Lettow, Frederik & de Coninck, Heleen & Felsmann, Balázs & Joltreau, Eugénie & Khandekar, Gauri & Linares, Pedro & Richstein, Jörn & Śniegocki, A, 2021, "A green COVID-19 recovery of the EU basic materials sector: identifying potentials, barriers and policy solutions," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, volume 21, issue 10, pages 1328-1346, DOI: 10.1080/14693062.2021.1922340.
• Banal-Estañol, Albert & Newham, Melissa & Seldeslachts, Jo, 2021, "Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, volume 66, issue 1, pages 68-99, DOI: 10.1177/0003603X20985796.
• Kirchhoff, Jasmina, 2021, "Mehr Arzneimittel 'made in Germany' über internationale Vernetzung: Industriepolitische Handlungsempfehlungen für eine zukunftsfähige Pharmaindustrie," IW policy papers, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 22/2021.
• Kirchhoff, Jasmina, 2021, "Die Rolle des Staates in der Impfstoffproduktion: Technologische Restriktionen und ökonomische Ableitungen," IW policy papers, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 3/2021.
• Kirchhoff, Jasmina & Schumacher, Simon, 2021, "Pharmaindustrie unter Pandemie-Bedingungen stabil: Konjunkturelle Entwicklung der pharmazeutischen Industrie im Jahr 2020," IW-Reports, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 3/2021.

2020

• Kenneth J. Arrow & L. Kamran Bilir & Alan Sorensen, 2020, "The Impact of Information Technology on the Diffusion of New Pharmaceuticals," American Economic Journal: Applied Economics, American Economic Association, volume 12, issue 3, pages 1-39, July, DOI: 10.1257/app.20170647.
• Jérôme Adda, 2020, "Preventing the Spread of Antibiotic Resistance," AEA Papers and Proceedings, American Economic Association, volume 110, pages 255-259, May, DOI: 10.1257/pandp.20201014.
• Jin Xie & Joseph Gerakos, 2020, "The Anticompetitive Effects of Common Ownership: The Case of Paragraph IV Generic Entry," AEA Papers and Proceedings, American Economic Association, volume 110, pages 569-572, May, DOI: 10.1257/pandp.20201029.
• Andrés López & Jeremías Lachman & Sebastián Gómez Roca, 2020, "Convirtiendo mercados negros en mercados legales: el largo y sinuoso camino del cannabis," Asociación Argentina de Economía Política: Working Papers, Asociación Argentina de Economía Política, number 4370, Nov.
• Muhamed Kudic & Mariia Shkolnykova, 2020, "From biotech to bioeconomy: New empirical evidence on the technological transition to plant-based bioeconomy based on patent data," Bremen Papers on Economics & Innovation, University of Bremen, Faculty of Business Studies and Economics, number 2002, Jan, DOI: https://doi.org/10.26092/elib/204.
• Iryna Budnikevych & Vadym Honchar, 2020, "Regulatory Mechanisms Of Ukrainian Pharmaceutical Market Competitiveness In The Context Of European Integration," Three Seas Economic Journal, Publishing house "Baltija Publishing", volume 1, issue 3, DOI: 10.30525/2661-5150/2020-3-1.
• Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020, "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," Working Papers, Becker Friedman Institute for Research In Economics, number 2020-162.
• Melissa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2020, "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Working Papers, Barcelona School of Economics, number 1216, Nov.
• Carrera, Mariana & Villas-Boas, Sofia B, 2020, "Generic Aversion and Observational Learning in the Over-the-Counter Drug Market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series, Department of Agricultural & Resource Economics, UC Berkeley, number qt7ks7s9jf, Dec.
• Zhili Tian & Ralph Siebert, 2020, "Dynamic Effects of Licensing and Knowledge Transfer across Research Stages: Evidence from the Pharmaceutical Industry," CESifo Working Paper Series, CESifo, number 8311.
• Mario Songane & Volker Grossmann, 2020, "The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value," CESifo Working Paper Series, CESifo, number 8488.
• Katrin Demmelhuber & Klaus Wohlrabe, 2020, "Branchen im Fokus: Chemische Industrie," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, volume 73, issue 02, pages 62-64, February.
• Sabine Rumscheidt, 2020, "Branchen im Fokus: Großhandel mit chemischen Erzeugnissen," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, volume 73, issue 03, pages 64-67, March.
• Martin Braml & Feodora Teti & Rahel Aichele, 2020, "Apotheke der Welt oder am Tropf der Weltwirtschaft? Deutschlands Außenhandel auf dem Markt für Arzneien und medizinische Ausrüstungen," ifo Schnelldienst, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, volume 73, issue 05, pages 35-42, May.
• Gersbach, Hans & Böttcher, Lucas, 2020, "A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development," CEPR Discussion Papers, C.E.P.R. Discussion Papers, number 15512, Dec.
• Borislav Boyanov, 2020, "European Chemical Industry – Current State and Challenges," Economic Archive, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, issue 1 Year 20, pages 57-72.
• Борислав Боянов, 2020, "Европейската Химическа Промишленост – Актуално Състояние И Предизвикателства," Economic Archive, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, issue 1 Year 20, pages 65-82.
• Jörn C. Richstein & Seyed Saeed Hosseinioun, 2020, "Industrial Demand Response: How Network Tariffs and Regulation Do (Not) Impact Flexibility Provision in Electricity Markets and Reserves," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 1853.
• Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020, "Common Ownership in the US Pharmaceutical Industry: A Network Analysis," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 1918.
• Olga Chiappinelli & Timo Gerres & Karsten Neuhoff & Frederik Lettow & Heleen de Coninck & Balázs Felsmann & Eugénie Joltreau & Gauri Khandekar & Pedro Linares & Jörn Richstein & Aleksander Śniegocki &, 2020, "A Green COVID-19 Recovery of the EU Basic Materials Sector: Identifying Potentials, Barriers and Policy Solutions," Discussion Papers of DIW Berlin, DIW Berlin, German Institute for Economic Research, number 1921.
• Alvarez E., Roberto & González, Aldo, 2020, "Análisis comparativo de los precios de los medicamentos en América Latina," Revista CEPAL, Naciones Unidas Comisión Económica para América Latina y el Caribe (CEPAL), April.
• Alvarez E., Roberto & González, Aldo, 2020, "A comparative analysis of medicine prices in Latin America," Revista CEPAL, Naciones Unidas Comisión Económica para América Latina y el Caribe (CEPAL), April.
• Richstein, Jörn C. & Hosseinioun, Seyed Saeed, 2020, "Industrial demand response: How network tariffs and regulation (do not) impact flexibility provision in electricity markets and reserves," Applied Energy, Elsevier, volume 278, issue C, DOI: 10.1016/j.apenergy.2020.115431.
• Lee, Chung-Ying, 2020, "Pricing strategy and moral hazard: Copay coupons in pharmaceuticals," International Journal of Industrial Organization, Elsevier, volume 70, issue C, DOI: 10.1016/j.ijindorg.2020.102611.
• Nasirov, Shukhrat, 2020, "Trademark value indicators: Evidence from the trademark protection lifecycle in the U.S. pharmaceutical industry," Research Policy, Elsevier, volume 49, issue 4, DOI: 10.1016/j.respol.2020.103929.
• Varun Mahajan, 2020, "Is productivity of Indian pharmaceutical industry affected with the introduction of product patent act?," Indian Growth and Development Review, Emerald Group Publishing Limited, volume 13, issue 1, pages 227-258, February, DOI: 10.1108/IGDR-11-2018-0116.
• Joanna Dyczkowska & Tomasz Dyczkowski, 2020, "Building Stakeholder Relations through Ongoing Engagement and Constructive Dialogue: Lessons from Large Biopharmaceutical Companies," European Research Studies Journal, European Research Studies Journal, volume 0, issue Special 2, pages 733-746.
• Albert Banal-Estanol & Melissa Newham & Jo Seldeslachts, 2020, "Common ownership in the US pharmaceutical industry: A network analysis," Working Papers of Department of Management, Strategy and Innovation, Leuven, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven, number 663270, Nov.
• Alenka Guzmán & Marco Antonio Pérez, 2020, "Extensión de la pandemia Covid-19 frente al acceso a la vacuna y las capacidades tecnológicas y de innovación del sector biofarmacéutico de México," Economía: teoría y práctica, Universidad Autónoma Metropolitana, México, volume 0, issue 2, pages 69-98, Diciembre, DOI: 10.24275/ETYPUAM/NE/E052020/Guzman.
• Gérard Mondello, 2020, "Construction de systèmes de croyances et éthique médicale: les controverses autour du Covid-19," GREDEG Working Papers, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France, number 2020-19, Jul, revised Feb 2022.
• Gérard Mondello, 2020, "Building Belief Systems and Medical Ethics: The Covid-19 Controversies," GREDEG Working Papers, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France, number 2020-35, Jul.
• de Roux, Nicolás & Eslava, Marcela & Franco, Santiago & Verhoogen, Eric, 2020, "Estimating Production Functions in Differentiated-Product Industries with Quantity Information and External Instruments," IZA Discussion Papers, Institute of Labor Economics (IZA), number 14006, Dec.
• Katharina E. Blankart & Frank R. Lichtenberg, 2020, "Are patients more adherent to newer drugs?," Health Care Management Science, Springer, volume 23, issue 4, pages 605-618, December, DOI: 10.1007/s10729-020-09513-5.
• Laura Borge & Stefanie Bröring, 2020, "What affects technology transfer in emerging knowledge areas? A multi-stakeholder concept mapping study in the bioeconomy," The Journal of Technology Transfer, Springer, volume 45, issue 2, pages 430-460, April, DOI: 10.1007/s10961-018-9702-4.
• Hugo Ernesto Martínez Ardila & Julián Eduardo Mora Moreno & Jaime Alberto Camacho Pico, 2020, "Networks of collaborative alliances: the second order interfirm technological distance and innovation performance," The Journal of Technology Transfer, Springer, volume 45, issue 4, pages 1255-1282, August, DOI: 10.1007/s10961-018-9704-2.
• Stefan Houweling & Sven Wolff, 2020, "The influence of scientific prestige and peer effects on the intention to create university spin-offs," The Journal of Technology Transfer, Springer, volume 45, issue 5, pages 1432-1450, October, DOI: 10.1007/s10961-019-09747-8.
• Jean-Paul Chavas & Guanming Shi & Kyle Stiegert, 2020, "Pricing and Industry Structure when Demand Elasticity Changes," Review of Industrial Organization, Springer;The Industrial Organization Society, volume 57, issue 4, pages 891-907, December, DOI: 10.1007/s11151-019-09745-y.
• Maé Geymond, 2020, "The influence of local institutional and historical frameworks on a globalized industry: The case of the pharmaceutical industry in France and Quebec," Documents de travail du Centre d'Economie de la Sorbonne, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne, number 20011, Jun.
• Michael Kremer & Jonathan D. Levin & Christopher M. Snyder, 2020, "Advance Market Commitments: Insights from Theory and Experience," NBER Working Papers, National Bureau of Economic Research, Inc, number 26775, Feb.
• Andrew W. Lo & Kien Wei Siah & Chi Heem Wong, 2020, "Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs," NBER Working Papers, National Bureau of Economic Research, Inc, number 27176, May.
• Bronwyn H. Hall, 2020, "Patents, Innovation, and Development," NBER Working Papers, National Bureau of Economic Research, Inc, number 27203, May.
• Matthew J. Higgins & Mathias J. Kronlund & Ji Min Park & Joshua Pollet, 2020, "The Role of Assets In Place: Loss of Market Exclusivity and Investment," NBER Working Papers, National Bureau of Economic Research, Inc, number 27588, Jul.
• Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020, "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," NBER Working Papers, National Bureau of Economic Research, Inc, number 28085, Nov.
• BĂRNUŢ Cătălin-Florin, 2020, "Stock Market Performance Analysis Of Pharmaceutical, It And Automotive Companies From Poland," Annals of Faculty of Economics, University of Oradea, Faculty of Economics, volume 1, issue 1, pages 177-188, July.
• Gabriela-Iuliana Paraschiv (Ganea) & Elena Condrea & Valentina Olteanu, 2020, "Biodegradable and Compostable Products – Essential Components for the Development of a Sustainable Bioeconomy," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, volume 0, issue 1, pages 211-218, August.
• Doina Margaritti & Cristina Tase, 2020, "Demand on the Pharmaceutical Market in the Conditions of the COVID-19 Health Crisis," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, volume 0, issue 2, pages 396-400, December.
• Raghbendra Jha & Ashok Sharma, 2020, "India's pharmaceutical industry: Global supply chain and governance in the post-COVID-19 world," ASARC Working Papers, The Australian National University, Australia South Asia Research Centre, number 2020-01.
• Jakub Growiec & Fabio Pammolli & Massimo Riccaboni, 2020, "Innovation and Corporate Dynamics: A Theoretical Framework," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, volume 12, issue 1, pages 1-45, March.
• Frank Lichtenberg, 2020, "The Health Impact of, and access to, New Drugs in Korea," East Asian Economic Review, Korea Institute for International Economic Policy, volume 24, issue 2, pages 127-164, DOI: 10.11644/KIEP.EAER.2020.24.2.374.
• Atsuko Kamiike, 2020, "The TRIPS Agreement and the Pharmaceutical Industry in India," Journal of Interdisciplinary Economics, , volume 32, issue 1, pages 95-113, January, DOI: 10.1177/0260107919875573.
• Meng-Chi Tang & Yi-Nong Wu, 2020, "Medical providers as double agents in a universal health care system: evidence from generic pharmaceutical adoption in Taiwan," Empirical Economics, Springer, volume 59, issue 1, pages 169-203, July, DOI: 10.1007/s00181-019-01674-9.
• Felicity Lamrock & Laura McCullagh & Lesley Tilson & Michael Barry, 2020, "A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 21, issue 6, pages 895-901, August, DOI: 10.1007/s10198-020-01181-0.
• Varun Mahajan & D. K. Nauriyal & S. P. Singh, 2020, "Domestic market competitiveness of Indian drug and pharmaceutical industry," Review of Managerial Science, Springer, volume 14, issue 3, pages 519-559, June, DOI: 10.1007/s11846-018-0299-7.
• Rena M. Conti & Ernst R. Berndt, 2020, "Four Facts Concerning Competition in US Generic Prescription Drug Markets," International Journal of the Economics of Business, Taylor & Francis Journals, volume 27, issue 1, pages 27-48, January, DOI: 10.1080/13571516.2019.1654324.
• F. Di Iorio & M. Letizia Giorgetti, 2020, "Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector," Industry and Innovation, Taylor & Francis Journals, volume 27, issue 7, pages 789-803, August, DOI: 10.1080/13662716.2019.1685373.
• Albert Banal-Estañol & Melissa Newham & Jo Seldeslachts, 2020, "Common ownership in the US pharmaceutical industry: A network analysis," Economics Working Papers, Department of Economics and Business, Universitat Pompeu Fabra, number 1752, Oct.
• Ralina Dobrinova Mircheva, 2020, "A Crisis Within the Crisis: The Impact of Covid-19 and Brexit On Supply Chains in the Pharmaceutical Industry," Business & Management Compass, University of Economics Varna, issue 3, pages 352-368.
• Deiana, C. & Giua, L. & Nisticò, R., 2020, "Opium Price Shocks and Prescription Opioids in the US," Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York, number 20/23, Dec.
• Richstein, Jörn C. & Hosseinioun, Seyed Saeed, 2020, "Industrial demand response: How network tariffs and regulation (do not) impact flexibility provision in electricity markets and reserves," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, volume 278.
• Döhler, Niklas & Wellenreuther, Claudia & Wolf, André, 2020, "Market dynamics of biodegradable bio-based plastics: Projections and linkages to European policies," HWWI Research Papers, Hamburg Institute of International Economics (HWWI), number 193.
• Wellenreuther, Claudia & Wolf, André, 2020, "Innovative feedstocks in biodegradable bio-based plastics: A literature review," HWWI Research Papers, Hamburg Institute of International Economics (HWWI), number 194.
• Diel, Anastasia & Kirchhoff, Jasmina, 2020, "Beschäftigungsstruktur der europäischen Pharmaindustrie: Ein Indikator für die Attraktivität eines Standorts?," IW-Reports, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 2/2020.
• Grömling, Michael & Kirchhof, Jasmina, 2020, "Produktions- und Zulieferstrukturen der deutschen Pharmaindustrie: Wie abhängig ist die Branche vom Ausland?
  [Production structures and supply chains in the German pharmaceutical sector: How dependent is the industry on foreign sources?]," IW-Trends – Vierteljahresschrift zur empirischen Wirtschaftsforschung, Institut der deutschen Wirtschaft (IW) / German Economic Institute, volume 47, issue 4, pages 23-44, DOI: 10.2373/1864-810X.20-04-02.

2019

• Emeric Henry & Marco Ottaviani, 2019, "Research and the Approval Process: The Organization of Persuasion," American Economic Review, American Economic Association, volume 109, issue 3, pages 911-955, March.
• Katalin Antalóczy & Tamás Gáspár & Magdolna Sass, 2019, "The Specialties of the Pharmaceutical Value Chains in Hungary," Acta Oeconomica, Akadémiai Kiadó, Hungary, volume 69, issue supplemen, pages 41-72, December.
• Frank R. Lichtenberg, 2019, "The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis," CESifo Working Paper Series, CESifo, number 7559.
• Aleksina, Anna & Akulenka, Stanislau & Lublóy, Ágnes, 2019, "Success Factors of Crowdfunding Campaigns in Medical Research: Perceptions and Reality," Corvinus Economics Working Papers (CEWP), Corvinus University of Budapest, number 2019/07, Jul.
• Карина Саркисян-Дикова & Борислав Боянов, 2019, "Въздействие На Европейските Екологични Регулации Върху Международната Конкурентоспособност На Предприятията От Химическата Промишленост В България," Scientific Research Almanac, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, volume 27, issue 1 Year 20, pages 253-278.
• Haucap, Justus & Rasch, Alexander & Stiebale, Joel, 2019, "How mergers affect innovation: Theory and evidence," International Journal of Industrial Organization, Elsevier, volume 63, issue C, pages 283-325, DOI: 10.1016/j.ijindorg.2018.10.003.
• Billette de Villemeur, Etienne & Versaevel, Bruno, 2019, "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, volume 65, issue C, pages 260-283, DOI: 10.1016/j.jhealeco.2019.01.002.
• Tylecote, Andrew, 2019, "Biotechnology as a new techno-economic paradigm that will help drive the world economy and mitigate climate change," Research Policy, Elsevier, volume 48, issue 4, pages 858-868, DOI: 10.1016/j.respol.2018.10.001.
• Mitze, Timo & Strotebeck, Falk, 2019, "Determining factors of interregional research collaboration in Germany's biotech network: Capacity, proximity, policy?," Technovation, Elsevier, volume 80, issue , pages 40-53, DOI: 10.1016/j.technovation.2018.11.001.
• Emeric Henry & Marco Ottaviani, 2019, "Research and the Approval Process: the Organization of Persuasion," Sciences Po Economics Publications (main), HAL, number hal-03391894, Mar, DOI: 10.1257/aer.20171919.
• Granlund, David, 2019, "A new approach to estimating state dependence in consumers’ brand choices applied to 762 pharmaceutical markets," Umeå Economic Studies, Umeå University, Department of Economics, number 960, Aug.
• Bibek Ray Chaudhuri & Sucharita Bhattacharyya & Susmita Chatterjee, 2019, "Pharmaceutical Exports and Patents in India – An Empirical Investigation," Working Papers, Indian Institute of Foreign Trade, number 1939, Jan.
• Toonika Rinken & Kairi Kivirand (ed.), 2019, "Biosensors for Environmental Monitoring," Books, IntechOpen, number 5929, ISBN: ARRAY(0x9839b840), June, DOI: 10.5772/intechopen.73763.
• Xudong Zhang & William Wang & Sunghoon Jang, 2019, "The Modeling, Design, Fabrication, and Application of Biosensor Based on Electric Cell-Substrate Impedance Sensing (ECIS) Technique in Environmental Monitoring," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.81178.
• Fabiano Luiz Naves, 2019, "Normal Boundary Intersection Applied to Controllers in Environmental Controls," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.83662.
• Amra Odobasic & Indira Sestan & Sabina Begic, 2019, "Biosensors for Determination of Heavy Metals in Waters," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.84139.
• Patricia S. Peixoto & Ana Machado & Helder P. Oliveira & Adriano A. Bordalo & Marcela A. Segundo, 2019, "Paper-Based Biosensors for Analysis of Water," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.84131.
• Kairi Kivirand & Mart Min & Toonika Rinken, 2019, "Challenges and Applications of Impedance-Based Biosensors in Water Analysis," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.89334.
• Flavio Colmati & Livia Florio Sgobbi & Guilhermina Ferreira Teixeira & Ramon Silva Vilela & Tatiana Martins & Giovanna Oliveira Figueiredo, 2019, "Electrochemical Biosensors Containing Pure Enzymes or Crude Extracts as Enzyme Sources for Pesticides and Phenolic Compounds with Pharmacological Property Detection and Quantification," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.84220.
• Eliana Mosse Alhadeff & Alfredo Jackson Telles Bosco & Caio Fragale Pastusiak & Thais Anjos Correia & Ninoska Isabel Bojorge Ramirez, 2019, "Development of an Ethanol Biosensor Based on Silver Nanoparticles/Polyaniline/Graphite/Epoxy Composite for Friendly Analytical Application," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.89359.
• Patricia Mussali-Galante & Efrain Tovar-Sanchez & Ramon Suarez-Rodriguez & Augusto Ramirez-Trujillo & Leticia Valencia-Cuevas & Isela Hernandez-Plata, 2019, "The Use of Biosensors for Biomonitoring Environmental Metal Pollution," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.84309.
• Geovany Albino De Souza & Tatiana Martins & Flavio Colmati, 2019, "Dynamic Luminescent Biosensors Based on Peptides for Oxygen Determination," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.84143.
• Umer Farooq & Qiaoli Yang & Muhammad Wajid Ullah & Shenqi Wang, 2019, "Principle and Development of Phage-Based Biosensors," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.86419.
• Toonika Rinken & Kairi Kivirand, 2019, "Introductory Chapter: The Prospective of Biosensing in Environmental Monitoring," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.85981.
• Shenqi Wang & Umer Farooq & Muhammad Wajid Ullah & Qiaoli Yang, 2019, "Applications of Phage-Based Biosensors in the Diagnosis of Infectious Diseases, Food Safety, and Environmental Monitoring," Chapters, IntechOpen, in: Toonika Rinken & Kairi Kivirand, "Biosensors for Environmental Monitoring", DOI: 10.5772/intechopen.88644.
• Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019, "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers, Institute of Labor Economics (IZA), number 12872, Dec.
• Annika Lorenz & Michael Raven & Knut Blind, 2019, "The role of standardization at the interface of product and process development in biotechnology," The Journal of Technology Transfer, Springer, volume 44, issue 4, pages 1097-1133, August, DOI: 10.1007/s10961-017-9644-2.
• Supriya Munshaw & Soo-Hoon Lee & Phillip H. Phan & Kieren A. Marr, 2019, "The influence of human capital and perceived university support on patent applications of biomedical investigators," The Journal of Technology Transfer, Springer, volume 44, issue 4, pages 1216-1235, August, DOI: 10.1007/s10961-018-9649-5.
• Richard G. Frank & Andrew Hicks & Ernst R. Berndt, 2019, "The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines," NBER Working Papers, National Bureau of Economic Research, Inc, number 26120, Jul.
• Rena M. Conti & Ernst R. Berndt, 2019, "Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets," NBER Working Papers, National Bureau of Economic Research, Inc, number 26194, Aug.
• Neriman Beste Kaygisiz & Yashna Shivdasani & Rena M. Conti & Ernst R. Berndt, 2019, "The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications," NBER Working Papers, National Bureau of Economic Research, Inc, number 26524, Dec.
• Yulia Nedelcheva, 2019, "Competitiveness In The Pharmaceutical Industry: A Historical Overview," Entrepreneurship, Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD, volume 7, issue 1, pages 36-47.
• Malyshev Victor & Kushchevska Nina & Korotieieva Antonina & Bruskova Diana-Maria & Lukashenko Tetiana & Zalubovskiy Mark, 2019, "Investigation of state, trends and structure of the world market of nanopowders," Technology audit and production reserves, 2(46) 2019, Socionet;Technology audit and production reserves, volume 2, issue 4(46), pages 34-42.
• Shevtsova Hanna & Maslosh Olha, 2019, "Chemical production modernization in the formative phase of Industry 4.0: study of trends and problems of investment support," Technology audit and production reserves, 1(45) 2019, Socionet;Technology audit and production reserves, volume 1, issue 4(45), pages 30-37.
• Malyshev Victor & Kushchevska Nina & Korotieieva Antonina & Bruskova Diana-Maria & Zalubovskiy Mark & Lukashenko Tetiana, 2019, "Analysis and systematization of marketing studies data of the Ukrainian nanopowder market and formation of the program for its development," Technology audit and production reserves, 3(47) 2019, Socionet;Technology audit and production reserves, volume 3, issue 4(47), pages 28-34.
• Ekaterina Bogomilova, 2019, "Analysis of Threats to the Physical Protection of Nuclear Facilities and Sites," Godishnik na UNSS, University of National and World Economy, Sofia, Bulgaria, issue 1, pages 253-264, December.
• Solon Moreira & Goretti Cabaleiro & Toke Reichstein, 2019, "Licensing decision: a rent dissipation lens applied to product market competition, openness to external knowledge and exogenous sunk costs," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, volume 28, issue 4, pages 773-792.
• Mary Donegan & Allison Forbes & Paige Clayton & Alyse Polly & Maryann Feldman & Nichola Lowe, 2019, "The tortoise, the hare, and the hybrid: effects of prior employment on the development of an entrepreneurial ecosystem," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, volume 28, issue 4, pages 899-920.
• Eduardo Morales & Gloria Sheu & Andrés Zahler, 2019, "Extended Gravity," The Review of Economic Studies, Review of Economic Studies Ltd, volume 86, issue 6, pages 2668-2712.
• Francesca Di Iorio & Maria Letizia Giorgietti, 2019, "Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector," DEM Working Papers Series, University of Pavia, Department of Economics and Management, number 169, Feb.
• Fujii, Hidemichi & Managi, Shunsuke & Kawahara, Hiromitsu, 2019, "The Pollution Release and Transfer Register System in the U.S. and Japan: An Analysis of Productivity," MPRA Paper, University Library of Munich, Germany, number 92235.
• Gaessler, Fabian & Wagner, Stefan, 2019, "Patents, Data Exclusivity, and the Development of New Drugs," Rationality and Competition Discussion Paper Series, CRC TRR 190 Rationality and Competition, number 176, Aug.
• Junghee Lee, 2019, "Study on the improvement of the enumeration of Legionella in environmental water samples using real-time PCR," Proceedings of International Academic Conferences, International Institute of Social and Economic Sciences, number 9711393, Oct.
• Pablo Montoro Leal & Juan Carlos García Mesa & María Mar López Guerrero & Elisa Isabel Vereda Alonso, 2019, "Synthesis and characterization of a new magnetic material join to graphene oxide as sorbent," Proceedings of International Academic Conferences, International Institute of Social and Economic Sciences, number 9811007, Oct.
• Farasat A.S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2019, "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK., number 2016-01v3, Oct.
• John Ashton & Tim Burnett & Ivan Diaz Rainey & Peter L. Ormosi, 2018, "Has the financial regulatory environment improved in the UK? Capture-Recapture approach to estimate detection and deterrence," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK., number 2018-03, Oct.
• Farasat A.S. Bokhari & Franco Mariuzzo & Weijie Yan, 2019, "Antibacterial resistance and the cost of affecting demand: the case of UK antibiotics," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK., number 2019-03, Jan.
• Izhak, Olena, 2019, "Extra costs of integrity: Pharmacy markups and generic substitution in Finland," DICE Discussion Papers, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE), number 307.
• Kirchhoff, Jasmina, 2019, "Auswirkungen des Brexits auf die deutsche Pharmaindustrie: Relevanz des Vereinigten Königreichs für pharmazeutische Unternehmen in Deutschland," IW-Reports, Institut der deutschen Wirtschaft (IW) / German Economic Institute, number 36/2019.

2018

• Pierre Dubois & Laura Lasio, 2018, "Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals," American Economic Review, American Economic Association, volume 108, issue 12, pages 3685-3724, December.